Stable CAD (Coronary artery disease)

This study evaluated the frequency and impact of periprocedural MI by using various MI definitions among patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).

This study aimed to increase the power to detect differences in patient survival (freedom from cardiac deaths) with IVUS versus angiography guidance by pooling the individual patient data from the IVUS-XPL and ULTIMATE trials.

Watch this session to discover a selection of cases on miscellaneous coronary interventions unveiled at GulfPCR-GIM 2021: imaging-guided multivessel PCI in left main with TVD with rotablation in a ESRD, tiger catheter-induced left main occlusion, using IVL instead of rotational atherectomy, PCI of LIMA-LAD at anastomotic site in single surviving artery, aortocoronary dissection...

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.

In this prespecified subgroup analysis of the AFIRE trial, the authors report the outcomes of rivaroxaban monotherapy compared to rivaroxaban and an antiplatelet agent in patients with atrial fibrillation who underwent coronary stenting > 1 year prior to enrolment.

The FUTURE Trial is a prospective randomised, multicentre, open label superiority trial comparing an FFR guided treatment strategy to traditional angiography guided treatment strategy on clinical outcomes in an all-comer population with multivessel coronary artery disease.

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

To further investigate the treatment effects of ticagrelor monotherapy compared with ticagrelor plus aspirin in a contemporary HBR population, a pre-specified analysis of the TWILIGHT trial, TWILIGHT-HBR, was conducted by using the Academic Research Consortium (ARC) criteria for HBR.